arrow
M

Marion Kainer

Royal Melbourne Hospital
H指数:38
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct Origins and Transmission Pathways of blaKPC Enterobacterales across Three US States

美国三个州的blaKPC肠杆菌的不同起源和传播途径

2023-07-133
OAAI
Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three US Sites
2023-06-152
OAAI
Epidemiology of Sepsis in US Children and Young Adults

美国儿童和年轻人脓毒症的流行病学

2023-04-206
OA
Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015
2023-01-0116
OAAI
Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial

Favipiravir在早期症状性新型冠状病毒肺炎中的应用,一项随机安慰剂对照试验

2022-12-0131
OAAI
State-wide genomic epidemiology investigations of COVID-19 in healthcare workers in 2020 Victoria, Australia: Qualitative thematic analysis to provide insights for future pandemic preparedness
2022-08-013
OAAI
Epidemiology of extended-spectrum β-lactamase-producing Enterobacterales in five US sites participating in the Emerging Infections Program, 2017
2022-02-1415
OA
Carbapenemase production among less-common Enterobacterales genera: 10 US sites, 2018
2021-09-049
OAAI
Antimicrobial Use in a Cohort of US Nursing Homes, 2017
2021-04-0626
OA
Assessment of the Appropriateness of Antimicrobial Use in US Hospitals

美国医院抗菌药物使用适当性评估

2021-03-1868
OAAI
Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant Enterobacterales in the United States
MBIO
IF4.7
2021-02-2343
OAAI
Association between Socioeconomic Status and Incidence of Community-Associated Clostridioides difficile Infection - United States, 2014-2015
2021-01-199
OA
Evaluation of Discrepancies in Carbapenem Minimum Inhibitory Concentrations Obtained at Clinical Laboratories Compared to a Public Health Laboratory
2020-11-021
OA